| Efficacy and Safety in a Randomised Acute Pain Study of MR308: STARDOM2. (NCT03062644) | Mundipharma Research GmbH & Co KG | 2017-04-05 |
| Efficacy and Safety in a Randomised Acute Pain Study of MR308 (Tramadol/Celecoxib). (NCT02982161) | Mundipharma Research GmbH & Co KG | 2016-12-28 |
| To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain (NCT02321397) | Mundipharma Research GmbH & Co KG | 2014-11-01 |
| A Single-arm, Study to Assess the Effect and Tolerability of Standardised Laxative Therapy (SLT) for the Reversal of Opioid-induced Constipation (OIC). (NCT01957046) | Mundipharma Research GmbH & Co KG | 2013-10-01 |
| A Study to Explore the Influence of Two Opioid Pain Medications on Bacterial Composition in the Gut and Other Gastrointestinal Aspects (NCT01915147) | Mundipharma Research GmbH & Co KG | 2013-07-01 |
| A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain (NCT01439100) | Mundipharma Research GmbH & Co KG | 2011-10-01 |
| A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy (NCT01438567) | Mundipharma Research GmbH & Co KG | 2011-09-01 |
| OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS) (NCT01197261) | Mundipharma Research GmbH & Co KG | 2010-09-01 |
| Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms (NCT01112644) | Mundipharma Research GmbH & Co KG | 2010-04-01 |
| Optimisation of Hydromorphone - Naloxone Ratio for the Treatment of Pain (NCT00992576) | Mundipharma Research GmbH & Co KG | 2010-01-01 |
| A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diabetic Polyneuropathy (NCT00944697) | Mundipharma Research GmbH & Co KG | 2009-07-01 |
| OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects (NCT00902837) | Mundipharma Research GmbH & Co KG | 2009-05-01 |
| A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain (NCT00513656) | Mundipharma Research GmbH & Co KG | 2007-09-01 |
| Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation (NCT00412100) | Mundipharma Research GmbH & Co KG | 2006-04-01 |
| Oxycodone-naloxone in Relieving Opioid-related Constipation (NCT00412152) | Mundipharma Research GmbH & Co KG | 2006-01-01 |
| A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain (NCT01971632) | Mundipharma Research GmbH & Co KG | 2005-01-01 |